{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:40:04Z","timestamp":1751053204233,"version":"3.41.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s13312-025-00034-4","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:59:44Z","timestamp":1744714784000},"page":"482-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum Immunoglobulin Levels in Children with Acute Lymphoblastic Leukemia During Maintenance Chemotherapy and its Association with Severe Febrile Illness"],"prefix":"10.1007","volume":"62","author":[{"given":"Maharshi","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-8391","authenticated-orcid":false,"given":"Priyakumari","family":"Thankamony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjusha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binitha","family":"Rajeswari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guruprasad Chellappan","family":"Sojamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shwetha","family":"Seetharam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth Varikkattu","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagathnath","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"34_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2017.74.4946","volume":"36","author":"M Schrappe","year":"2018","unstructured":"Schrappe M, Bleckmann K, Zimmermann M, et al. Reduced-Intensity delayed intensification in standard-risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018;36:244\u201353.","journal-title":"J Clin Oncol"},{"key":"34_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1200\/JCO.19.01086","volume":"38","author":"KW Maloney","year":"2020","unstructured":"Maloney KW, Devidas M, Wang C, et al. Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: Results of children\u2019s oncology group trial AALL0331. J Clinic Oncol. 2020;38:602\u201312.","journal-title":"J Clinic Oncol"},{"key":"34_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/pbc.20018","volume":"42","author":"W Luczynski","year":"2004","unstructured":"Luczynski W, Stasiak-Barmuta A, Krawczuk-Rybak M. Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children\u2014preliminary report. Pediatr Blood Cancer. 2004;42:416\u201320.","journal-title":"Pediatr Blood Cancer"},{"key":"34_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","volume":"124","author":"D O\u2019Connor","year":"2014","unstructured":"O\u2019Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124:1056\u201361.","journal-title":"Blood"},{"key":"34_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2141.1980.tb03809.x","volume":"45","author":"NT Rapson","year":"1980","unstructured":"Rapson NT, Cornbleet MA, Chessells JM, et al. Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes. Br J Haematol. 1980;45:41\u201352.","journal-title":"Br J Haematol"},{"key":"34_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2141.2009.07862.x","volume":"147","author":"M Eyrich","year":"2009","unstructured":"Eyrich M, Wiegering V, Lim A, et al. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia\u2014a prospective study of 20 paediatric patients. Br J Haematol. 2009;147:360\u201370.","journal-title":"Br J Haematol"},{"key":"34_CR7","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/sj.leu.2404326","volume":"20","author":"CM van Tilburg","year":"2006","unstructured":"van Tilburg CM, Sanders EAM, Rovers MM, et al. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006;20:1717\u201322.","journal-title":"Leukemia"},{"key":"34_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00043426-200411000-00008","volume":"26","author":"T Ek","year":"2004","unstructured":"Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol. 2004;26:727\u201334.","journal-title":"J Pediatr Hematol Oncol"},{"key":"34_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/IJPM.IJPM_542_16","volume":"60","author":"G Narula","year":"2017","unstructured":"Narula G, Khodaiji S, Bableshwar A, et al. Age-related reference intervals for immunoglobulin levels and lymphocyte subsets in Indian children. Indian J Pathol Microbiol. 2017;60:360\u20134.","journal-title":"Indian J Pathol Microbiol"},{"key":"34_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MPH.0000000000001415","volume":"41","author":"EA Holmes","year":"2019","unstructured":"Holmes EA, Friedman DL, Connelly JA, et al. Impact of IgG monitoring and IVIG supplementation on the frequency of febrile illnesses in pediatric acute lymphoblastic leukemia patients undergoing maintenance chemotherapy. J Pediatr Hematol Oncol. 2019;41:423\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"key":"34_CR11","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","volume":"111","author":"A M\u00f6ricke","year":"2008","unstructured":"M\u00f6ricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477\u201389.","journal-title":"Blood"},{"key":"34_CR12","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 Update. J Clin Oncol. 2017;35:2082\u201394.","journal-title":"J Clin Oncol"},{"key":"34_CR13","unstructured":"Meites S, Buffone G. Pediatric clinical chemistry: reference (normal) values. 1989. Accessed on Nov 2, 2024. Available from: https:\/\/www.semanticscholar.org\/paper\/Pediatric-clinical-chemistry-%3A-reference-(normal)-Meites-Buffone\/17e86bcb5553dd39702194d4c067ccb78bc8691f"},{"key":"34_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/pbc.23258","volume":"58","author":"CM van Tilburg","year":"2012","unstructured":"van Tilburg CM, Bierings MB, Berbers GAM, et al. Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases. Pediatr Blood Cancer. 2012;58:701\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"34_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1532\/IJH97.E0317","volume":"80","author":"S Kostaridou","year":"2004","unstructured":"Kostaridou S, Polychronopoulou S, Psarra K, et al. Decrease of CD4 + and B-lymphocyte populations is not associated with severe infectious complications in children with acute lymphoblastic leukemia during maintenance. Int J Hematol. 2004;80:354\u201360.","journal-title":"Int J Hematol"},{"key":"34_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/000456329102800507","volume":"28","author":"A Haraldsson","year":"1991","unstructured":"Haraldsson A, Kock-Jansen MJ, Jaminon M, et al. Determination of kappa and lambda light chains in serum immunoglobulins G, A and M. Ann Clin Biochem. 1991;28:461\u20136.","journal-title":"Ann Clin Biochem"},{"key":"34_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1179\/102453308X316086","volume":"13","author":"FA El-Chennawi","year":"2008","unstructured":"El-Chennawi FA, Al-Tonbary YA, Mossad YM, et al. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection. Hematology. 2008;13:203\u20139.","journal-title":"Hematology"},{"key":"34_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/annonc\/mdw557","volume":"28","author":"H Inaba","year":"2017","unstructured":"Inaba H, Pei D, Wolf J, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017;28:386\u201392.","journal-title":"Ann Oncol"},{"key":"34_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jped.2018.07.013","volume":"96","author":"S Abdelmabood","year":"2020","unstructured":"Abdelmabood S, Fouda AE, Boujettif F, et al. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: High mortalities, early relapses, and poor survival. J Pediatr (Rio J). 2020;96:108\u201316.","journal-title":"J Pediatr (Rio J)"},{"key":"34_CR20","first-page":"337","volume":"57","author":"W Luczy\u0144ski","year":"2004","unstructured":"Luczy\u0144ski W, Stasiak-Barmuta A, Krawczuk-Rybak M, et al. Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections. Wiad Lek. 2004;57:337\u201342.","journal-title":"Wiad Lek"},{"key":"34_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/08880019309016546","volume":"10","author":"PE Lovat","year":"1993","unstructured":"Lovat PE, Robinson JH, Windebank KP, et al. Serial study of t lymphocytes in childhood leukemia during remission. Pediatr Hematol Oncol. 1993;10:129\u201339.","journal-title":"Pediatr Hematol Oncol"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1182\/blood.V73.6.1608.1608","volume":"73","author":"MS Borzy","year":"1989","unstructured":"Borzy MS, Ridgway D. Prolonged defects of interleukin-2 production, responsiveness, and receptor expression in patients with acute lymphoblastic leukemia. Blood. 1989;73:1608\u201314.","journal-title":"Blood"},{"key":"34_CR23","first-page":"4661","volume":"44","author":"DH Boldt","year":"1984","unstructured":"Boldt DH, Von Hoff DD, Kuhn JG, et al. Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5\u2019-monophosphate (NSC 312887), a new purine antimetabolite. Cancer Res. 1984;44:4661\u20136.","journal-title":"Cancer Res"},{"key":"34_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1172\/JCI108982","volume":"61","author":"BF Haynes","year":"1978","unstructured":"Haynes BF, Fauci AS. The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest. 1978;61:703\u20137.","journal-title":"J Clin Invest"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-025-00034-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00034-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:04:39Z","timestamp":1751051079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-025-00034-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s13312-025-00034-4","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"type":"print","value":"0019-6061"},{"type":"electronic","value":"0974-7559"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None stated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"IRB No. 01\/2018\/12 dated Jan 30, 2018.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics clearance"}}]}}